PTGS2 and posterior cortical atrophy: Treatment with apigenin leads to down-regulation of NF-κB-regulating genes, such as Bcl-2, cyclooxygenase-2 (COX-2) and matrix metalloproteinase 9 (MMP-9), and sensitizes hormone-refractory PCa cells to TNFα-induced apoptosis [33].